K-115 phase 3 long-term administration study
Phase 3
- Conditions
- POAG, exfoliative glaucoma, pigmentary glaucoma or OH
- Registration Number
- JPRN-jRCT2080221525
- Lead Sponsor
- Kowa Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 350
Inclusion Criteria
1.POAG, exfoliative glaucoma, pigmentary glaucoma or OH patients
2.Baseline IOP >= 15mmHg
Exclusion Criteria
1.Patients whose visual acuity is below 0.3
2.Patients thought to use glaucoma medication
3.Patients thought to wear contact lenses
etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method